MARKET

MRK

MRK

Merck & Co
NYSE
114.24
+1.68
+1.49%
After Hours: 113.99 -0.25 -0.22% 19:00 05/19 EDT
OPEN
112.56
PREV CLOSE
112.56
HIGH
115.10
LOW
112.13
VOLUME
7.55M
TURNOVER
--
52 WEEK HIGH
124.22
52 WEEK LOW
72.76
MARKET CAP
282.15B
P/E (TTM)
32.14
1D
5D
1M
3M
1Y
5Y
1D
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
NASDAQ · 4h ago
Tectonic Therapeutics: Currently In A Catalyst Vacuum
Seeking Alpha · 5h ago
Trump Trade: Trump announces expansion of TrumpRx.gov
TipRanks · 9h ago
Jefferies Reaffirms Their Buy Rating on Merck & Company (MRK)
TipRanks · 9h ago
Exelixis announces clinical development collaboration with Merck
TipRanks · 10h ago
Exelixis Enters Clinical Development Collaboration With Merck For Its KEYTRUDA QLEX Injection In Combination With Zanzalintinib In The STELLAR-316 Phase 3 Trial
Benzinga · 10h ago
Analysts Offer Insights on Healthcare Companies: Marker Therapeutics (MRKR), Merck & Company (MRK) and Cullinan Management (CGEM)
TipRanks · 11h ago
Zoetis Inc. Stock Rallies 4.7%, Outperforms Peers
Dow Jones · 1d ago
More
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.